Alpha Tau Medical
(NASDAQ) DRTS
Alpha Tau Medical Financials at a Glance
Market Cap
$616.95M
Revenue (TTM)
$0.00
Net Income (TTM)
$42.63M
EPS (TTM)
$-0.53
P/E Ratio
-13.28
Dividend
$0.00
Beta (Volatility)
0.53 (Low)
Dividend
$0.00
Beta (Volatility)
0.53 (Low)
Price
$7.01
Volume
9,372
Open
$7.18
Price
$7.01
Volume
9,372
Open
$7.18
Previous Close
$7.01
Daily Range
$6.90 - $7.27
52-Week Range
$2.30 - $8.60
Dividend
$0.00
Beta (Volatility)
0.53 (Low)
Price
$7.01
Volume
9,372
Open
$7.18
Previous Close
$7.01
Daily Range
$6.90 - $7.27
52-Week Range
$2.30 - $8.60
DRTS News
DRTS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Alpha Tau Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
112
CEO
Uzi Sofer, MBA
Website
www.alphatau.comHeadquarters
Jerusalem, 9777605, IL
DRTS Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-61%
Return on Capital
18%
Return on Assets
-40%
Earnings Yield
-7.53%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$616.95M
Shares Outstanding
88.01M
Volume
9.37K
Short Interest
0.00%
Avg. Volume
350.77K
Financials (TTM)
Gross Profit
$1.23M
Operating Income
$42.29M
EBITDA
$41.06M
Operating Cash Flow
$26.68M
Capital Expenditure
$6.08M
Free Cash Flow
$32.76M
Cash & ST Invst.
$76.90M
Total Debt
$13.73M
Alpha Tau Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$616.95M
N/A
Market Cap/Employee
$4.94M
N/A
Employees
125
N/A
Net Income
$12.14M
-28.1%
EBITDA
$12.60M
-133.5%
Quarterly Fundamentals
Net Cash
$63.18M
+34.2%
Accounts Receivable
$36.00K
-89.2%
Inventory
$0.00
N/A
Long Term Debt
$12.60M
+9.3%
Short Term Debt
$1.13M
-44.1%
Return on Assets
-40.00%
N/A
Return on Invested Capital
17.78%
N/A
Free Cash Flow
$32.76M
N/A
Operating Cash Flow
$26.68M
N/A